Abstract:The advent of single-cell RNA sequencing (scRNA-Seq) has brought with it the ability to gain greater insights into the cellular composition of tissues and heterogeneity in gene expression within specific cell types. For tissue-engineered blood vessels, this is particularly impactful to better understand how neotissue forms and remodels into tissue resembling a native vessel. A notable challenge, however, is the ability to separate cells from synthetic biomaterials to generate high-quality single-cell suspensions to interrogate the cellular composition of our tissue-engineered vascular grafts (TEVGs) during active remodeling in situ. We present here a simple, commercially available approach to separate cells within our TEVG from the residual scaffold for downstream use in a scRNA-Seq workflow. Utilizing this method, we identified the cell populations comprising explanted TEVGs and compared these with results from immunohistochemical analysis. The process began with explanted TEVGs undergoing traditional mechanical and enzymatic dissociation to separate cells from scaffold and extracellular matrix proteins. Magnetically labeled antibodies targeting murine origin cells were incubated with enzymatic digests of TEVGs containing cells and scaffold debris in suspension allowing for separation by utilizing a magnetic separator column. Single-cell suspensions were processed through 10 × Genomics and data were analyzed utilizing R to generate cell clusters. Expression data provided new insights into a diverse composition of phenotypically unique subclusters within the fibroblast, macrophage, smooth muscle cell, and endothelial cell populations contributing to the early neotissue remodeling stages of TEVGs. These populations were correlated qualitatively and quantitatively with immunohistochemistry highlighting for the first time the potential of scRNA-Seq to provide exquisite detail into the host cellular response to an implanted TEVG. These results additionally demonstrate magnetic cell isolation is an effective method for generating high-quality cell suspensions for scRNA-Seq. While this method was utilized for our group's TEVGs, it has broader applications to other implantable materials that use biodegradable synthetic materials as part of scaffold composition. Impact statement Single-cell RNA sequencing is an evolving technology with the ability to provide detailed information on the cellular composition of remodeling biomaterials in vivo. This present work details an effective approach for separating nondegraded biomaterials from cells for downstream RNA-sequencing analysis. We applied this method to implanted tissue-engineered vascular grafts and for the first time describe the cellular composition of the remodeling graft at a single-cell gene expression level. While this method was effective in our scaffold, it has broad applicability to other implanted biomaterials that necessitate separation of cell from residual scaffold materials for single-cell RNA sequencing.

Single-cell transcriptomics in tissue engineering and regenerative medicine

Nanomaterial-based cell sheet technology for regenerative medicine and tissue engineering

Implanted Tissue-Engineered Vascular Graft Cell Isolation with Single-Cell RNA Sequencing Analysis

Tissue engineering and cell based therapies, from the bench to the clinic: the potential to replace, repair and regenerate

Towards systems tissue engineering: Elucidating the dynamics, spatial coordination, and individual cells driving emergent behaviors

Advances in single-cell sequencing: insights from organ transplantation

Exploiting Single-Cell Tools in Gene and Cell Therapy

Single-cell RNA sequencing in cardiovascular development, disease and medicine

The Advancement and Application of the Single-Cell Transcriptome in Biological and Medical Research

Transcriptomic Approaches to Cardiomyocyte-Biomaterial Interactions: A Review

Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics

Single-cell analysis of the cellular heterogeneity and interactions in the injured mouse spinal cord

Cardiac cellular diversity and functionality in cardiac repair by single-cell transcriptomics

Potential applications of deep learning in single-cell RNA sequencing analysis for cell therapy and regenerative medicine

Musculoskeletal tissue engineering by endogenous stem/progenitor cells

Engineered biomaterials for in situ tissue regeneration

Single‐cell profiling for advancing birth defects research and prevention

Regenerative Medicine and Immunotherapies

The future of cell-instructive biomaterials for tissue regeneration–a perspective from early career clinician-scientists

Direct cell reprogramming for tissue engineering and regenerative medicine